Cargando…
Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer
Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer compared with luminal or epidermal growth factor receptor 2 subtypes, thus effective therapeutic options for TNBC are yet to be developed. Nowadays, oncogenic long noncoding RNAs (lncRNAs) are applied to cancer management...
Autores principales: | Mitobe, Yuichi, Ikeda, Kazuhiro, Sato, Wataru, Kodama, Yukinobu, Naito, Mitsuru, Gotoh, Noriko, Miyata, Kanjiro, Kataoka, Kazunori, Sasaki, Hitoshi, Horie‐Inoue, Kuniko, Inoue, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385350/ https://www.ncbi.nlm.nih.gov/pubmed/32437068 http://dx.doi.org/10.1111/cas.14498 |
Ejemplares similares
-
Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020) -
Long Intergenic Noncoding RNA OIN1 Promotes Ovarian Cancer Growth by Modulating Apoptosis-Related Gene Expression
por: Takeiwa, Toshihiko, et al.
Publicado: (2021) -
Roles of Splicing Factors in Hormone-Related Cancer Progression
por: Takeiwa, Toshihiko, et al.
Publicado: (2020) -
PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2
por: Takeiwa, Toshihiko, et al.
Publicado: (2022) -
Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
por: Horie, Kuniko, et al.
Publicado: (2022)